We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Enzyme Assay on Impregnated Filter Paper Detects Krabbe Disease

By LabMedica International staff writers
Posted on 26 Jan 2015
Krabbe disease (KD) is an inherited lysosomal storage disease (LSD) caused by the deficiency of galactocerebrosidase (GALC) and is characterized by a severe and progressive leukodystrophy with death frequently before one year of life.

Dried-blood filter paper (DBFP) samples have been increasingly used for lysosomal enzyme assay and some lysosomal enzymes could not be tested in DBFP samples using fluorometric assays, including GALC, heparan-sulfamidase and a few others.

Medical Geneticists at the Hospital de Clínicas de Porto Alegre (Brazil) obtained leucocytes from healthy individuals and confirmed KD patients. More...
Dried-leukocytes filter paper (DLFP) samples were prepared by diluting a pellet of leukocytes in distilled water and the solution was mixed, sonicated on ice bath in a Misonix Sonicator XL2020 (Qsonica; Newtown, CT, USA). After incubation with suitable substrates supernatants were measured on SpectraMax M2 spectrofluorometer (Molecular Devices; Sunnyvale, CA, USA).

When GALC activities in DLFP and their corresponding leukocyte samples were compared, it is possible to see a close correlation in the respective KD groups. The healthy control group showed higher values of activities in DLFP, possibly due to some degree of protein retention in the filter paper in the dilution process. The investigators did not visualize this effect in the KD samples, probably because the fluorescence of these samples is very low. Nevertheless, the assay in DLFP allowed the correct identification of KD patients in all cases.

The authors concluded that the assay of GALC on DLFP is a reliable and useful method for the identification of KD. As sample preparation is feasible in standard biochemical laboratories and as transportation is very simple, it could enable patients living in remote areas to be investigated and diagnosed. The study was published on January 1, 2015, in the journal Clinica Chimica Acta.

Related Links:

Hospital de Clínicas de Porto Alegre
Qsonica
Molecular Devices



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.